Uncategorized
Self-retained amniotic membrane ‘promising’ treatment for ocular surface health
LOS ANGELES —Placement of self-retained cryopreserved amniotic membrane in patients with moderate to severe dry eye disease improved symptoms, improved the ocular surface and reduced dry eye disease severity for at least 3 months, according to a speaker here.“Placement of self-retained amniotic membrane is a promising therapy to accelerate the recovery of ocular surface health in patients with moderate to severe dry eye disease,” Marguerite B. McDonald, MD, said at the American Society of Cataract and Refractive Surgery meeting.